Compare INDI & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INDI | PACB |
|---|---|---|
| Founded | 2007 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 688.9M | 567.6M |
| IPO Year | N/A | 2010 |
| Metric | INDI | PACB |
|---|---|---|
| Price | $3.54 | $2.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $6.25 | $2.00 |
| AVG Volume (30 Days) | 4.0M | ★ 10.8M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $217,396,000.00 | $154,584,000.00 |
| Revenue This Year | $4.53 | $6.06 |
| Revenue Next Year | $31.60 | $15.15 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.53 | $0.85 |
| 52 Week High | $6.05 | $2.73 |
| Indicator | INDI | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 35.82 | 59.96 |
| Support Level | $3.15 | $2.24 |
| Resistance Level | $3.68 | $2.73 |
| Average True Range (ATR) | 0.27 | 0.21 |
| MACD | -0.05 | 0.06 |
| Stochastic Oscillator | 22.09 | 65.88 |
Indie Semiconductor Inc is empowering the Autotech revolution with next-generation automotive semiconductors and software platforms. It focuses on edge sensors for Driver Assistance Systems including LiDAR, connected car, user experience, and electrification applications. These technologies represent the core underpinnings of both electric and autonomous vehicles, while the user interfaces transform the in-cabin experience to mirror and seamlessly connect to the mobile platforms. Geographically, the company generates majority of its revenue from Greater China and rest from United States, Europe, South Korea and other regions.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.